In ₹ Crore except Per Share Latest Annual	NATHBIOGEN FY26	SARVESHWAR FY26	INDOUS FY26	SUKHJITS FY26	Peer Average
Valuation — at last close
P/E	◆ 6.31×	12.24×	11.98×	25.20×	16.47× -62%
P/B	◆ 0.37×	0.92×	1.70×	0.78×	1.13× -67%
EV/EBITDA	◆ 5.99×	10.34×	11.05×	8.29×	9.89× -39%
Market Cap	₹252 Cr	₹437 Cr	₹157 Cr	₹445 Cr	₹346 Cr -27%
Growth
Revenue CAGR 3Y	13.88%	◆ 24.98%	—	-0.33%	12.33% +13%
Net Income CAGR 3Y	5.93%	◆ 59.78%	—	-24.72%	17.53% -66%
Revenue YoY (latest Q)	15.76%	18.81%	-51.22%	◆ 29.71%	-0.90% +1851%
Net Income YoY (latest Q)	-13.46%	17.04%	-206.35%	◆ 255.12%	21.94% -161%
Profitability
EBITDA Margin	11.78%	4.91%	◆ 15.40%	5.77%	8.69% +36%
Net Income Margin	9.35%	2.36%	◆ 11.88%	1.89%	5.38% +74%
Return on Common Equity	6.28%	8.13%	◆ 15.34%	4.87%	9.45% -34%
Return on Capital Employed	7.11%	16.11%	◆ 18.40%	6.48%	13.66% -48%
Return on Assets	3.92%	3.19%	◆ 11.36%	2.55%	5.70% -31%
Credit & Quality
Total Debt/Equity	◆ 0.20×	0.52×	0.40×	0.58×	0.50× -60%
Interest Coverage	3.03×	2.44×	◆ 7.18×	1.54×	3.72× -19%
Scale — latest FY
Revenue / Total Income	₹445 Cr	₹1,346 Cr	₹110 Cr	₹1,432 Cr	₹963 Cr -54%
Net Income	₹41.6 Cr	₹31.8 Cr	₹13.1 Cr	₹27 Cr	₹24 Cr +74%
Total Assets	₹1,097 Cr	₹1,089 Cr	₹133 Cr	₹1,089 Cr	₹770 Cr +42%
EPS	₹20.98	₹0.29	₹6.54	₹5.65	₹4.16 +404%
Book Value per Share	₹358.06	₹3.87	₹46.15	₹181.61	₹77.21 +364%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.